CSF Proteomic Profiling Reveals Altered Pathways in Myotonic Dystrophy Type 1 (P2-11.029)
To identify myotonic dystrophy type 1 (DM1) biomarkers through a comprehensive proteomic evaluation of cerebrospinal fluid (CSF) from patients.
Authors
- Jacinda B. Sampson (ORCID: https://orcid.org/0000-0002-4991-6496)
- Katharine A. Hagerman (ORCID: https://orcid.org/0000-0002-1790-8221)
- John Day (ORCID: https://orcid.org/0000-0002-0086-9529)
- Tahereh Kamali (ORCID: https://orcid.org/0000-0002-7455-9013)
- Marwa Zafarullah (ORCID: https://orcid.org/0000-0003-1856-0535)
- Lisa Ghiglieri
Institutions
- Stanford University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211981
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00